A share of BioVie Inc (NASDAQ:BIVI) closed at $1.25 per share on Friday, up from $1.24 day before. While BioVie Inc has overperformed by 0.81%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, BIVI fell by -78.96%, with highs and lows ranging from $11.39 to $1.14, whereas the simple moving average fell by -74.94% in the last 200 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

On July 22, 2022, Cantor Fitzgerald started tracking BioVie Inc (NASDAQ: BIVI) recommending Overweight.

Analysis of BioVie Inc (BIVI)

BioVie Inc’s future performance can be predicted by a variety of well-rounded types of analysis and research, with equity being one of the most crucial ones. The goal here is to ensure that your current return on equity of -748.41% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.72, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can be an extremely valuable indicator of volatility, and BIVI is registering an average volume of 758.21K. On a monthly basis, the volatility of the stock is set at 11.21%, whereas on a weekly basis, it is put at 9.00%, with a loss of -13.79% over the past seven days. Furthermore, long-term investors anticipate a median target price of $5.00, showing growth from the present price of $1.25, which can serve as yet another indication of whether BIVI is worth investing in or should be passed over.

How Do You Analyze BioVie Inc Shares?

Besides checking the fundamentals, you should also know how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 62.77%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 5.46% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

Are institutional investors increasing their holdings in BIVI shares?

The recent increase in stakes in BIVI appears to be a result of several institutional investors and hedge funds increasing their positions. Ikarian Capital LLC’s position in BIVI has increased by 1.96% in the first quarter. The company now owns 457,345 shares of the stock, with a value of $0.82 million, following the purchase of 8,789 additional shares during the last quarter. swisspartners Marcuard Heritage A made another increased to its shares in BIVI during the first quarter, upping its stake by 82.82%. During the last quarter, the company picked up 133,346 additional shares for a total stake of worth $0.53 million, bringing number of shares owned by the company to 294,346.

During the first quarter, The Vanguard Group, Inc. added a 21,052 position in BIVI. Geode Capital Management LLC sold an additional 13061.0 shares in the last quarter, decreasing its holdings by -8.62%, now holding 0.14 million shares worth $0.25 million. At the end of the first quarter, Boothbay Fund Management LLC increased its BIVI holdings by 9.58% and now holds 0.1 million BIVI shares valued at $0.18 million with the added 8789.0 shares during the period. BIVI shares are owned by institutional investors to the tune of 5.46% at present.

Leave a Reply

Your email address will not be published. Required fields are marked *